Does Cigna Cover Prolia?
The verdict
Covered on most plans
Cigna covers Prolia under the medical benefit with prior authorization, most often as a clinician-administered subcutaneous injection billed under HCPCS J0897 every 6 months. When denosumab routes through the pharmacy benefit, Express Scripts manages the formulary and Accredo provides specialty-pharmacy dispensing. Biosimilar preference for Jubbonti (denosumab-bddz) is emerging across the industry, and Express Scripts, like other big-three PBMs, has been aggressive on biosimilar substitution. Not covered outside approved osteoporosis and bone-loss indications.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Cigna using your member ID.
Key facts
Cigna uses Express Scripts as its PBM and Accredo as its specialty pharmacy — when Prolia routes through the pharmacy benefit, these two entities manage formulary placement and dispensing.
Cigna/Express Scripts formulary and specialty pharmacy network, 2025
Prolia is most often a Medicare Part B buy-and-bill drug billed under HCPCS J0897 — not a Part D pharmacy pickup. The $2,100 Part D OOP cap does not apply to the Part B medical pathway.
CMS Local Coverage Determination L33394; Medicare.gov
Express Scripts removed branded Humira from its largest commercial formulary for 2025 in favor of biosimilars — illustrating the PBM's aggressive biosimilar substitution posture that is also driving Jubbonti adoption.
Express Scripts 2025 National Preferred Formulary announcement
Medicare vs. commercial coverage
Whether Cigna covers Prolia depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage / Medicare Prescription Drug Plan (Part B medical benefit): Prolia is covered as a clinician-administered subcutaneous injection every 6 months, billed under HCPCS J0897 incident to a physician service per LCD L33394. On Cigna Medicare Advantage plans, prior authorization is required with documentation of osteoporosis and high fracture risk. Observed Medicare plan copays range $0–$500 per injection depending on plan design — the 20% Part B coinsurance structure applies on the medical-benefit pathway. A Cigna Medigap supplement typically covers the 20% coinsurance on Original Medicare. Biosimilar preference for Jubbonti is emerging on Medicare plans. The $2,100 Part D out-of-pocket cap does NOT apply to the Part B medical-benefit pathway — this is a critical distinction for members comparing Prolia costs to Part D specialty drugs.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Prolia is covered under the medical benefit with PA via Cigna's medical policy; documentation of osteoporosis with high fracture risk (T-score at or below -2.5, prior fragility fracture, or high FRAX score) required. PA approval typically 12 months. Where the pharmacy-benefit pathway applies — such as when site of care shifts — Express Scripts manages the formulary and Accredo provides specialty dispensing. Express Scripts has been aggressive on biosimilar substitution industry-wide, and biosimilar preference for Jubbonti is expected to follow. ACA/Individual: covered with PA where Cigna offers individual-market plans. Medicaid: Cigna-managed Medicaid covers Prolia for osteoporosis with high fracture risk per state PDL at nominal cost-share with PA. Not covered outside FDA-approved indications.
The 3 boxes you must tick to get approved
Commercial plans that will consider Prolia require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Prolia actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,786–$2,507 per 60 mg dose without insurance (estimates: Medicare.org ~$1,786; GoodRx ~$2,507). Actual cash price varies by site of care.
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Advantage (Cigna): observed copays across Medicare plans range $0–$500 per injection depending on plan design — verify on your specific Cigna MA plan. Original Medicare with Cigna Medigap supplement: 20% Part B coinsurance after Part B deductible; Medigap typically covers the 20%. Commercial/Employer: medical-benefit coinsurance per Cigna plan; varies by plan design. Medicaid: nominal cost-share per state PDL.
Typical monthly copay once prior authorization is approved.
Bridge program
Amgen offers copay support for Prolia for commercially insured patients. This program is NOT available to Medicare or Medicaid beneficiaries under federal anti-kickback rules.
Reduced copay through the assistance program, where eligible.
All figures are estimates. The Part D $2,100 out-of-pocket cap does NOT apply to the Part B medical pathway. Verify your specific cost-share on the Cigna member portal (mycigna.com) or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Check Cigna's medical policy for denosumab and confirm your benefit routing
Log in to mycigna.com and search for 'Prolia' or 'denosumab' under your plan's drug and medical benefits. For most Medicare members, Prolia is a Part B medical-benefit drug — look under medical benefits (not the drug formulary). Confirm whether your plan routes Prolia through the medical benefit (billed to the clinic) or the pharmacy benefit (Express Scripts/Accredo).
- 2
Ask your prescriber about Jubbonti and current Express Scripts biosimilar policy
Express Scripts has moved aggressively to biosimilar products across drug classes. Your prescribing clinician can check whether Cigna's current formulary requires Jubbonti (denosumab-bddz) before branded Prolia for your line of business. If branded Prolia is currently authorized, confirm that your existing authorization remains valid or whether a transition to Jubbonti is expected.
- 3
Verify your cost-share for a Part B clinic injection vs. a Part D specialty drug
Because Prolia is most often a Part B drug, your cost-share is 20% of the Medicare-approved amount after the Part B deductible — not a Part D tier copay. The $2,100 Part D cap does not apply. If you have a Cigna Medigap supplement, it typically covers the 20%. Call Cigna member services at the number on your ID card for a cost estimate specific to your plan and your site of care.
Options if Cigna won't cover Prolia
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Jubbonti (denosumab-bddz)
The FDA-approved interchangeable biosimilar for Prolia, same 60 mg denosumab molecule and q6-month injection schedule. Express Scripts, Cigna's PBM, is expected to align with the industry move toward Jubbonti preference. Existing Prolia authorizations typically transition automatically when a plan adopts the biosimilar.
Fosamax (alendronate) — generic bisphosphonate
Oral generic bisphosphonate, typically Tier 1. Common first-line osteoporosis treatment. Prior bisphosphonate use history may be considered in some PA evaluations.
Reclast (zoledronic acid)
Annual IV bisphosphonate infusion administered in a clinic and billed under the medical benefit. Typically covered at lower cost-share than Prolia. An option for patients who cannot tolerate oral bisphosphonates.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
For most Cigna Medicare and commercial members, Prolia is covered under the medical benefit — administered as a clinic injection every 6 months and billed under HCPCS J0897, not picked up at a pharmacy. When the pharmacy-benefit pathway applies, Express Scripts manages the formulary and Accredo handles specialty dispensing. Confirm your specific routing with your clinician or on the Cigna member portal, as this determines which cost-sharing structure applies.
Express Scripts is Cigna's pharmacy benefit manager — it manages the drug formulary for Cigna members when Prolia routes through the pharmacy benefit. Accredo is Cigna's specialty pharmacy. When denosumab is dispensed (rather than administered in a clinician's office billed to the medical benefit), Express Scripts and Accredo are the operational pathway. Express Scripts has been aggressive on biosimilar substitution, so confirm the current Jubbonti vs. Prolia policy on your plan.
No, not on the Part B medical-benefit pathway. For most Cigna Medicare members, Prolia is billed under Part B as a clinic-administered drug — not as a Part D pharmacy drug. The $2,100 Part D out-of-pocket cap (2026) applies to Part D drugs only. Part B cost-sharing is the 20% coinsurance after the Part B deductible. A Cigna Medigap supplement typically covers that 20%. Verify your routing with Cigna member services.
Biosimilar preference for Jubbonti (denosumab-bddz) is emerging across major insurers, and Express Scripts has historically moved quickly to biosimilar substitution. Whether Cigna currently requires a biosimilar step before branded Prolia depends on your specific plan year and line of business. Ask your prescriber to check the current PA status for denosumab on your Cigna plan before initiating treatment.
On a Cigna Medigap supplement with Original Medicare, your cost is typically 20% of the Part B-approved amount after the deductible — Medigap usually covers this 20%. On a Cigna Medicare Advantage plan, observed copays across Medicare plans range $0–$500 per injection depending on plan design; verify on your specific plan. Cash price without coverage is estimated at $1,786–$2,507 per 60 mg dose. All figures are estimates — verify on mycigna.com or with member services.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Cigna before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.